Evolent Health, Inc. (NYSE:EVH) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET

Company Participants

Seth Frank – Vice President-Investor Relations

Seth Blackley – Chief Executive Officer

John Johnson – Chief Financial Officer

Conference Call Participants

Jeff Garro – Stephens

Sean Dodge – RBC Capital

Ryan Daniels – William Blair

Charles Rhyee – TD Cowan

David Larsen – BTIG

Sandy Draper – Guggenheim

Jessica Tassan – Piper Sandler

Richard Close – Canaccord Genuity

Jailendra Singh – Truist

Operator

Welcome to the Evolent Earnings Conference Call for the Quarter Ending June 30, 2023. As a reminder, this conference call is being recorded. Your host for the call today from Evolent are Seth Blackley, Chief Executive Officer; and John Johnson, Chief Financial Officer. This call will be archived and available later this evening and for the next week via the webcast on the company’s website in the section entitled Investor Relations.

I will now hand the call to Seth Frank, Evolent’s Vice President of Investor Relations. Please go ahead.

Seth Frank

Thank you, and good evening. This conference call will contain forward-looking statements under the U.S. federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company’s reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company’s results and outlook, please refer to our second quarter press release issued earlier today.

Finally, as a reminder, reconciliations of non-GAAP measures discussed during today’s call to the most direct comparable GAAP measures are available in the summary presentation available in the Investor Relations section of our website or in the company’s press release issued today and posted on the Investor Relations section of the company’s website ir.evolenthealth.com and Form 8-K filed by the company with the SEC earlier today.

During management’s presentation and discussion will reference certain GAAP and non-GAAP figures and metrics that can be found in our earnings release as well as a summary presentation available on the Events section of Evolent’s IR website, ir.evolenthealth.com.

And now with that, I’ll turn the call over to Evolent’s CEO, Seth Blackley.

Seth Blackley

Good evening, and thanks for joining us. We’re pleased to be here to discuss another strong quarter of execution against our plan. As context for today’s call, I want to reiterate three key elements of that plan. First, organic growth driven by a conviction that our integrated value-based specialty management approach is a winning strategy for both attracting new clients and expanding with existing clients.